Article
Emerging small-molecule treatments for multiple sclerosis: focus on B cells
2019-03-01
Abstract excerpt
Multiple sclerosis (MS) is a major cause of disability in young adults. Following an unknown trigger (or triggers), the immune system attacks the myelin sheath surrounding axons, leading to progressive nerve cell death. Antibodies and small-molecule drugs directed against B cells have demonstrated good efficacy in slowing progression of the disease. This review focusses on small-molecule drugs that can affect B-ce...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 8ae7b9e6-6953-5708-803c-271cbc9dbc3c
- DOI
- 10.12688/f1000research.16495.1